N-Hydroxyisobutyramidine

Catalog No.: 
ACGNSQ196
CAS No.: 
35613-84-4
Molecular Formula: 
C4H10N2O
Molecular Weight: 
102.14
N-Hydroxyisobutyramidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%
10g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Hydroxyisobutyramidine
IUPAC NameN-hydroxyisobutyrimidamide
MDL No.MFCD03426251
Molecular FormulaC4H10N2O
Molecular Weight102.14
SMILESCC(C)C(NO)=N
InChI KeyJHRDEHLFNLLCQS-UHFFFAOYSA-N
SynonymN'-hydroxy-2-methylpropanimidamide | 35613-84-4 | N-Hydroxyisobutyramidine | (Z)-N'-Hydroxyisobutyrimidamide | 849833-56-3 | (1Z)-N'-Hydroxy-2-methylpropanimidamide | N-Hydroxyisobutyrimidamide | N'-Hydroxy-2-methylpropanamidine | N-Hydroxy-2-methylpropanimidamide | 120285
CAS No.35613-84-4
PubChem CID9582835

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P310-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGNSQ196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGNSQ196 route product structure diagram
    ACGNSQ19635613-84-4In Stock
Inquiry

2. ACGNSQ196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGNSQ196 route product structure diagram
    ACGNSQ19635613-84-4In Stock
Inquiry

3. ACGNSQ196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGNSQ196 route product structure diagram
    ACGNSQ19635613-84-4In Stock
Inquiry

Comments (0)